Cerus (CERS) announced the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood System for platelets and plasma under the European Union ...

Cerus Corporation has obtained CE mark approval for its INT200, a light-emitting diode (LED)-based illumination device, for ...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood ...

Regulatory Approval Allows Company to Initiate Commercialization of the Illumination Device throughout the European Union Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of ...